UK Elderly Care Market Forecast To Reach Capacity By 2033
The UK’s elderly care market is forecast to capacity by 2033 without a wave of new development, according to new analysis by global real estate advisor Knight Frank.
Knight Frank’s Healthcare Development Opportunities Report 2026 shows that the net supply of UK care beds has grown by just 136 over the past year to 480,000, with a 24% year-on-year uptick in new home completions offset by supply leakage and the rising deregistration of older stock.
Supply leakage is particularly acute in London. While the West Midlands recorded a net gain of almost 1,500 beds from 2017 to 2025, the capital saw a decline of c.2,000 beds over the same period. In total, Knight Frank’s analysis reveals that care home bed supply has expanded by just 2.4% over the past decade, starkly lagging the 16.2% growth in the UK’s over-65 population. Planning approvals granted for 2026 were also lower than those for 2025, signalling a narrowing development pipeline and a widening gap between planning consent and delivery. Together, these trends underscore the impending care supply crisis facing the UK and the critical need for accelerated development to meet the needs of a rapidly ageing population.
Existing care home bed supply across the UK is also in urgent need of upgrading. 79% of homes are more than 20 years old, rendering many as functionally obsolete. 38% of homes have also been converted from other uses, meaning they are often not meeting modern expectations, particularly with respect to resident wellbeing and the provision of ensuite facilities. Quality concerns further underscore the challenge, with almost one in five (19%) UK care homes currently rated by the Care Quality Commission as “Requires Improvement” or “Inadequate”.
This creates an opportunity for investors and operators to invest in modernising existing stock, as well as developing new, purpose-built beds to accommodate future demand. The Covid-19 pandemic highlighted the importance of high-quality elderly care provision, supporting demand for modern, wellbeing-centric stock. Additionally, ESG-focused capex unlocks opportunities for investors to secure meaningful valuation and income uplifts across existing care facilities.
Site selection is crucial for investors and operators seeking to increase their exposure to the UK market. Knight Frank has created a Development Hotspots Index to identify UK regions with the strongest case for future development, analysing counties across England, Wales and Scotland against a series of key metrics such as demographic projections, land values, supply pipeline and operational performance indicators. Knight Frank’s Index revealed South Glamorgan in Wales, Lothian in Scotland and Berkshire in England as the areas with the strongest care home development prospects in the UK. Bedfordshire, Wiltshire and Greater Manchester also scored highly.
Julian Evans, Global Head of Healthcare at Knight Frank, commented: “The Covid-19 pandemic brought the UK care market into sharp focus, underscoring the critical need for an adequate supply of purpose-built beds capable of meeting the complex needs of a rapidly ageing population. Despite a record year for UK healthcare investment in 2025, Knight Frank’s analysis demonstrates that supply is failing to keep pace with demand. Without a significant acceleration in both investment and development to upgrade standing stock and deliver new beds in core markets, the UK is fast approaching a crisis in care provision, with domestic bed capacity projected to reach saturation by the end of the decade.”
Ryan Richards, Healthcare Research Associate at Knight Frank, added: “The critical undersupply of UK care home beds represents both a national imperative to deliver new stock and a rare opportunity for investors and operators. Strong demographic tailwinds and favourable supply-demand fundamentals underpin an attractive long-term investment case across the sector. Our analysis identifies the UK regions where the case for new development potential is strongest, serving as a research-driven guide for investors seeking to maximise income performance whilst also alleviating the risk of a national care crisis in the coming years.”
